Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 14;187(23):6760-6779.e24.
doi: 10.1016/j.cell.2024.09.001. Epub 2024 Sep 30.

Spatially exploring RNA biology in archival formalin-fixed paraffin-embedded tissues

Affiliations

Spatially exploring RNA biology in archival formalin-fixed paraffin-embedded tissues

Zhiliang Bai et al. Cell. .

Abstract

The capability to spatially explore RNA biology in formalin-fixed paraffin-embedded (FFPE) tissues holds transformative potential for histopathology research. Here, we present pathology-compatible deterministic barcoding in tissue (Patho-DBiT) by combining in situ polyadenylation and computational innovation for spatial whole transcriptome sequencing, tailored to probe the diverse RNA species in clinically archived FFPE samples. It permits spatial co-profiling of gene expression and RNA processing, unveiling region-specific splicing isoforms, and high-sensitivity transcriptomic mapping of clinical tumor FFPE tissues stored for 5 years. Furthermore, genome-wide single-nucleotide RNA variants can be captured to distinguish malignant subclones from non-malignant cells in human lymphomas. Patho-DBiT also maps microRNA regulatory networks and RNA splicing dynamics, decoding their roles in spatial tumorigenesis. Single-cell level Patho-DBiT dissects the spatiotemporal cellular dynamics driving tumor clonal architecture and progression. Patho-DBiT stands poised as a valuable platform to unravel rich RNA biology in FFPE tissues to aid in clinical pathology evaluation.

Keywords: RNA biology; clinical FFPE tissue; histopathology; microRNA; single-nucleotide RNA variants; spatial omics; spatiotemporal dynamics; splicing isoforms; whole transcriptome.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests Z.B. and R.F. are inventors of a patent application related to this work. R.F. is scientific founder and adviser for IsoPlexis, Singleron Biotechnologies, and AtlasXomics. The interests of R.F. were reviewed and managed by Yale University Provost’s Office in accordance with the University’s conflict of interest policies. M.L.X. has served as consultant for Treeline Biosciences, Pure Marrow, and Seattle Genetics. Daiwei Zhang and M.L. are co-founders or OmicPath AI LLC. M.L. receives research funding from Biogen Inc. unrelated to the current manuscript.

Update of

References

    1. Baysoy A, Bai Z, Satija R, and Fan R (2023). The technological landscape and applications of single-cell multi-omics. Nat Rev Mol Cell Biol 24, 695–713. 10.1038/s41580-023-00615-w. - DOI - PMC - PubMed
    1. Bressan D, Battistoni G, and Hannon GJ (2023). The dawn of spatial omics. Science 381, eabq4964. doi:10.1126/science.abq4964. - DOI - PMC - PubMed
    1. Deng Y, Bai Z, and Fan R (2023). Microtechnologies for single-cell and spatial multi-omics. Nature Reviews Bioengineering 1, 769–784. 10.1038/s44222-023-00084-y. - DOI
    1. Chen J, Larsson L, Swarbrick A, and Lundeberg J (2024). Spatial landscapes of cancers: insights and opportunities. Nature Reviews Clinical Oncology. 10.1038/s41571-024-00926-7. - DOI - PubMed
    1. Harries LW (2019). RNA Biology Provides New Therapeutic Targets for Human Disease. Front Genet 10, 205. 10.3389/fgene.2019.00205. - DOI - PMC - PubMed